One large retrospective study of gastroenteropancreatic neuroendocrine neoplasms examined SSTR-2 in 163 patients with high grade gastroenteropancreatic neuroendocrine tumors or cancer of unknown primary. This evidence concerns the gene SSTR2 and neuroendocrine neoplasm.